BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 23176724)

  • 1. Optimizing multiple myeloma treatment: conclusions.
    Palumbo A
    Leuk Res; 2012 Nov; 36 Suppl 1():S44-5. PubMed ID: 23176724
    [No Abstract]   [Full Text] [Related]  

  • 2. Optimizing therapy for transplant-eligible patients with newly diagnosed multiple myeloma.
    Moreau P; Giralt SA
    Leuk Res; 2012 Nov; 36 Suppl 1():S13-8. PubMed ID: 23176719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Initial therapy for multiple myeloma].
    Shimizu K
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():589-96. PubMed ID: 23134020
    [No Abstract]   [Full Text] [Related]  

  • 4. Frontline therapy in multiple myeloma: fast start for a long game.
    Patriarca F
    Lancet Haematol; 2019 Dec; 6(12):e600-e601. PubMed ID: 31624046
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent advances in the management of multiple myeloma.
    Kumar L; Verma R; Radhakrishnan VR
    Natl Med J India; 2010; 23(4):210-8. PubMed ID: 21192514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute lymphoblastic leukaemia-type intensive chemotherapy to eliminate minimal residual disease after high-dose melphalan and autologous transplantation in multiple myeloma - a phase I/II feasibility and tolerance study of 17 patients.
    Powles R; Sirohi B; Kulkarni S; Bhagwati N; Saso R; Raje N; Horton C; Singhal S; Mehta J; Treleaven J
    Bone Marrow Transplant; 2000 May; 25(9):949-56. PubMed ID: 10800062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple myeloma in the elderly.
    Cohen HJ
    Clin Geriatr Med; 1985 Nov; 1(4):827-55. PubMed ID: 3913521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The intensive treatment of multiple myeloma with support from hematopoietic progenitors].
    Paz-Ares L; Lahuerta J; Montes A
    Med Clin (Barc); 1997 Feb; 108(6):226-9. PubMed ID: 9102490
    [No Abstract]   [Full Text] [Related]  

  • 9. [clinical study and physiopathology of multiple myeloma].
    Kuramoto A
    Nihon Naika Gakkai Zasshi; 1992 Sep; 81(9):1335-47. PubMed ID: 1453054
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical roundtable monograph. Emerging treatment options for relapsed and refractory multiple myeloma.
    Siegel DS; Vij R; Jakubowiak AJ
    Clin Adv Hematol Oncol; 2011 Apr; 9(4):1-15. PubMed ID: 21928467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple myeloma: recognition and management.
    George ED; Sadovsky R
    Am Fam Physician; 1999 Apr; 59(7):1885-94. PubMed ID: 10208707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic role of minimal residual disease in multiple myeloma patients after non-myeloablative allogeneic transplantation.
    Galimberti S; Benedetti E; Morabito F; Papineschi F; Callea V; Fazzi R; Stelitano C; Andreazzoli F; Guerrini F; Ciabatti E; Martino M; Nobile F; Iacopino P; Petrini M
    Leuk Res; 2005 Aug; 29(8):961-6. PubMed ID: 15978948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NCCN: Multiple myeloma.
    Traynor AE; Noga SJ;
    Cancer Control; 2001; 8(6 Suppl 2):78-87. PubMed ID: 11760563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multiple myeloma].
    Krome S
    Dtsch Med Wochenschr; 2012 Mar; 137 Suppl 1():S14-7. PubMed ID: 22438117
    [No Abstract]   [Full Text] [Related]  

  • 15. Multiple myeloma and its treatment.
    Felder B
    Clin J Oncol Nurs; 2002; 6(6):359-62. PubMed ID: 12434469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel approaches in the treatment of multiple myeloma.
    Abedi M; Elfenbein GJ
    Med Health R I; 2003 Aug; 86(8):231-5. PubMed ID: 14582216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple myeloma: epidemiology and therapeutic options.
    Tuscano JM
    Manag Care; 2008 Jul; 17(7 Suppl 6):9-15. PubMed ID: 19093334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the significance of molecular remission in multiple myeloma?
    Tricot GJ
    Clin Adv Hematol Oncol; 2007 Feb; 5(2):91-5. PubMed ID: 17344796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current role of immunotherapy in multiple myeloma.
    Hájek R; Adam Z; Krivanová A; Doubek M; Korístek Z; Vorlícek J
    Acta Med Austriaca; 1998; 25(3):79-85. PubMed ID: 9816399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of the patient with multiple myeloma and renal failure.
    Warwicker P; Summerfield G; Cove-Smith R
    Br J Hosp Med; 1994 Jun 1-14; 51(11):582-8. PubMed ID: 7952747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.